Consumers choose online channels that provide more convenient and greater access to various brands. This encourages them to make bulk purchases and spend larger amounts. According to a survey, it was found that ~16.7% of diet supplements were made online in 2020, a 64% rise from 2019. The online category is estimated to register 25% of diet supplement sales by 2024. A few companies dominate the diet pills market; however, all market players have varied the distribution channels, as the internet reduced a few challenges to access these products. For instance, consumers have better access to health and nutrition information with active media telecasts, lifestyle blogs, and social media. Further, corporations are enhancing their advertising efforts and product development budgets.
With the new features and technologies, vendors attract new customers to grow their footprints in emerging markets. This factor is likely to drive the SAM diet pills market. The SAM diet pills market is expected to grow at a substantial CAGR during the forecast period.
SAM Diet Pills Market Segmentation
The SAM diet pills market is segmented into product type, application, age group, distribution channel, and country. Based on product type, the SAM diet pills market is segmented into prescription, herbal supplements, and over the counter drugs. The prescription segment dominated the market in 2020. Based on application, the SAM diet pills market is segmented into appetite suppression, fat blocking, metabolism raising pills, and others. The appetite suppression segment led the market in 2020. Based on age group, the SAM diet pills market is bifurcated into adults and teenagers. The adults segment dominated the market in 2020. Based on distribution channel, the SAM diet pills market is segmented into hospital pharmacies, online pharmacies, and retail pharmacies & drug stores. The hospital pharmacies segment led the market in 2020. Based on country, the SAM diet pills market is segmented into Brazil, Argentina, and the Rest of SAM. The Brazil segment dominated the market in 2020.
Pfizer Inc. (Arena Pharmaceutical GMBH), Novo Nordisk A/S, GlaxoSmithKline plc, Lovate Health Sciences International Inc., TEVA Pharmaceutical Industries LTD, and Chong’s Health Care are among the leading companies operating in the SAM diet pills market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 76.11 Million |
| Market Size by 2028 | US$ 146.02 Million |
| CAGR (2021 - 2028) | 9.8% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South America Diet Pills Market is valued at US$ 76.11 Million in 2021, it is projected to reach US$ 146.02 Million by 2028.
As per our report South America Diet Pills Market, the market size is valued at US$ 76.11 Million in 2021, projecting it to reach US$ 146.02 Million by 2028. This translates to a CAGR of approximately 9.8% during the forecast period.
The South America Diet Pills Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Diet Pills Market report:
The South America Diet Pills Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South America Diet Pills Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South America Diet Pills Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South America Diet Pills Market
